Northwest Biotherapeutics News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

19.12.16	NW Bio Announces Initiation Of Trading On The OTCQB Marketplace Starting On Monday Morning, December 19, 2016 (PR Newswire)
08.12.16	NW Bio Provides Update About Phase 3 Trial Of DCVax®-L for Newly Diagnosed Glioblastoma Multiforme Brain Cancer (PR Newswire)
08.12.16	NWBO To Leave Nasdaq, Voyager Cruises Ahead, Watch Out For REGN (RTTNews)
08.12.16	NW Bio Announces Decision to Voluntarily Withdraw from Nasdaq Listing and Begin Trading on OTC Market (PR Newswire)
05.12.16	Biotech Stocks on Investors' Radar -- Northwest Biotherapeutics, ACADIA Pharma, Acorda Therapeutics, and Ultragenyx Pharma (PR Newswire)
03.05.16	Northwest Bio Heading North, PRTK To Report Data In June, FLML Gets FDA Nod (RTTNews)
24.08.15	VTL Plunges As Trial Flops, NWBO Sets It Straight, Court Rules In Favor Of MDXG (RTTNews)
20.02.15	Mark Your Calendar For TCON, XLRN, Xenon Lights Up, MACK Gets Going (RTTNews)
10.06.14	Northwest Bio Initiates Phase III DCVax-L Trial In Germany - Quick Facts (RTTNews)
11.03.14	La Jolla Shines, ETRM Gets New Decision Date, NWBO Going North, RGDO Explodes (RTTNews)
07.03.14	NW Bio Gets Recommendation To Continue With Last-stage GBM Brain Cancer Trial (RTTNews)
20.11.13	Northwest Biotherapeutics Prices $23.5 Mln Offering Of Stock, Warrants (RTTNews)
24.09.13	NW Bio Activates Second Site in DCVax-Direct Phase I/II Trial (PR Newswire)
18.09.13	L'organisme de réglementation allemand autorise l'ouverture de l'essai GBM de phase III de NW Bio (PR Newswire)
17.09.13	Deutsche Zulassungsbehörde genehmigt den Start der Phase-III-GBM-Studie von NW Bio (PR Newswire)
17.09.13	German Regulator Oks Northwest Biotherapeutics' Late-stage GBM Trial To Open (RTTNews)
17.09.13	German Regulator Authorizes NW Bio's Phase III GBM Trial To Open (PR Newswire)
10.09.13	NW Bio's Patent Portfolio Further Expanded With Manufacturing Automation Patent (PR Newswire)
09.08.13	Northwest Biotherapeutics Announces Registered Direct Offering (PR Newswire)
09.08.13	NW Bio Receives Regulatory Decision That Will Enable Its Phase III Brain Cancer Trial To Proceed In Germany (PR Newswire)
01.08.13	Anika On A Roll, AEZS Makes That First Step, KERX To Watch Out For, STAAR Shines (RTTNews)
31.07.13	NW Bio Announces Above-Market Conversion of its $11.6 Million Debt to Its Manufacturer, Cognate Bioservices (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V